Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Avalo Therapeutics
(C6K0.F) Q2 2024
Earnings
C6K0.F
May 13
Confirmed
Q2 2024
-130.63
-87.45
-44.27
-1.09
Details
Expected EPS
-1.0932464
Actual EPS
-130.63368
Surprise EPS
-129.54
Surprise Percent
-11,849.15%
Description
Avalo Therapeutics (C6K0.F) has reported earnings of -130.63368 per share for Q2 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login